Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants With Nonsegmental Vitiligo
Vitiligo is a long-term autoimmune condition that causes the skin to lose its color. The body's germ-fighting system (immune system) mistakenly attacks the ski…
Nonsegmental Vitiligo
Estimated
~$10 – $7,500
TakedaNCT07108283
Phase 3
A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.
NonSegmental Vitiligo
Estimated
~$10 – $8,750
Incyte CorporationNCT06548360